← brief for 2026-10-01 · Slowing decline

GLP-1 receptor agonists-a potential therapy for chronic kidney disease?

Paper No results yet Peer reviewed

Key takeaways

This review discusses whether GLP-1 drugs, often used for diabetes, can help slow kidney decline. It summarizes existing evidence but does not report new trial results. There are no new data from this item.

Who did this work

Boeckhaus J · Sayer JA · Mabillard H

Source

Paper · PubMed, CKD progression · 2026 Oct 14
https://pubmed.ncbi.nlm.nih.gov/42820470/